PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine and Cytometry General Service-Nucleus, CIBERONC, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain.\', \'Department of Critical Care Medicine, Hospital Universitario de Getafe, Madrid, Spain.\', \'CIBER de Enfermedades Respiratorias, Instituto de Investigación Carlos III, Madrid, Spain.\', \'Fundación de Investigación Biomédica del Hospital Universitario de Getafe, Madrid, Spain.\', \'Functional Proteomics Laboratory, National Center for Biotechnology, Consejo Superior de Investigaciones Científicas, Madrid, Spain.\', \'PROTEORED-ISCIII, Red Nacional de Laboratorios de Proteomica-ISCIII, Madrid, Spain.\', \'Bioinformatics and Functional Genomics Group, Cancer Research Center (IBMCC, CSIC/USAL/IBSAL), Consejo Superior de Investigaciones Científicas & University of Salamanca, Salamanca, Spain.\', \'Universidad Europea de Madrid, Madrid, Spain.\', \'Proteomics Unit, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2022.732197
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35154090
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all